Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | HTT | P42858 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 2/20 | 0.51 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.48 |
| ▸ | FAAH | O00519 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | ATM | Q13315 | 2/20 | 0.48 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | P4HB | P07237 | 1/20 | 0.47 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.47 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14496362 | 0.87 | ALDH1A1 (0.49) | SMN1; SMN2ALDH1A1HTTPOLBKDM4E | |
| SCHEMBL19049372 | 0.86 | HRH3 (0.66) | SMN1; SMN2GAAALDH1A1HTTPOLB | |
| SCHEMBL1005987 | 0.85 | FAAH (0.54) | SMN1; SMN2GAAPOLBSIGMAR1FAAH | |
| SCHEMBL19002246 | 0.83 | HRH3 (0.55) | SMN1; SMN2ALDH1A1HTTPOLBKDM4E | |
| SCHEMBL24827581 | 0.83 | SMN1; SMN2 (0.50) | SMN1; SMN2GAAALDH1A1HTTPOLB | |
| SCHEMBL19002674 | 0.83 | SMN1; SMN2 (0.48) | SMN1; SMN2GAAALDH1A1HTTPOLB | |
| SCHEMBL3245833 | 0.80 | ATM (0.71) | SMN1; SMN2ALDH1A1HTTPOLBFAAH | |
| SCHEMBL1006605 | 0.80 | VEGFA (0.55) | SMN1; SMN2GAAHTTSIGMAR1FAAH | |
| SCHEMBL14642155 | 0.79 | HRH3 (0.54) | SMN1; SMN2ALDH1A1HTTPOLBKDM4E | |
| SCHEMBL27760871 | 0.79 | LMNA (0.58) | SMN1; SMN2ALDH1A1HTTPOLBKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170174699-A1 | COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE | SHY Therapeutics LLC | 2017-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170174699-A1 | COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE | MAPK6, MAP3K6, MAPK4 | SMN1; SMN2 4331/4885GAA 2713/4885ALDH1A1 2765/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.